Reduction in osteomyelitis and septic arthritis related to Haemophilus influenzae type B vaccination

J Pediatr Orthop. 1999 Nov-Dec;19(6):705-9.

Abstract

This retrospective cohort study compares organisms responsible for septic arthritis and osteomyelitis before and after Haemophilus influenzae type b vaccination. Before vaccination, Haemophilus influenzae type b was responsible for 5% of culture positive osteomyelitis and 41% of culture positive septic arthritis. Since the administration of the conjugated vaccine PRP-T began in 1992, no case of osteomyelitis or septic arthritis has been caused by Haemophilus influenzae type b (p < 0.005, t test). Vaccination has succeeded in eliminating Haemophilus influenzae type b as an infective agent in hematogenous septic arthritis and osteomyelitis. Current empirical antibiotic therapy for hematogenous septic arthritis and osteomyelitis need only cover gram-positive agents in vaccinated infants and children of all age groups.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Distribution
  • Arthritis, Infectious / epidemiology
  • Arthritis, Infectious / prevention & control*
  • Canada / epidemiology
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Haemophilus Infections / prevention & control*
  • Haemophilus Vaccines / administration & dosage*
  • Haemophilus influenzae type b / immunology*
  • Humans
  • Incidence
  • Infant
  • Male
  • Osteomyelitis / epidemiology
  • Osteomyelitis / prevention & control*
  • Retrospective Studies
  • Sex Distribution

Substances

  • Haemophilus Vaccines